Chinabio Today -- A new partnership has been established that will investigate traditional Chinese medicines for a new, more effective treatment of tuberculosis. The Institute of Microbiology (IMCAS), a member institute of the Chinese Academy of Sciences, will team up with the Global Alliance for TB Drug Development (TB Alliance) to do the work. IMCAS, which is located in Beijing, has completed a pilot screen that identified 24 natural product extracts as having potential anti-tubercular activity. IMCAS and the TB Alliance will collaborate to test these extracts further.
